Haplo-HSCT appears comparable to fully matched HSCTOctober 9, 2015CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantation
Method can identify CTCL quickly, study suggestsOctober 9, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
JAK inhibitors could treat Sézary syndrome, team saysOctober 8, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Treating EBV-associated lymphomas with VSTsOctober 6, 2015Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin Lymphoma
Living conditions linked to risk of Hodgkin lymphomaOctober 2, 2015Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Group calls for more investment in radiotherapyOctober 1, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Nonviral gene transfer of CARs tested in humansSeptember 30, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantationALL
Problems in pediatric cancer care in EuropeSeptember 30, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
Pregnant cancer patients: Start treatment ASAPSeptember 29, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Variations in blood cancer survival across EuropeSeptember 28, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLHodgkin LymphomaCMLNon-Hodgkin Lymphoma
NICE backs discounted idelalisib for CLLSeptember 27, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Childhood cancer increases material hardshipSeptember 25, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
Reducing side effects of CAR T-cell therapySeptember 25, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Insights from the 5-year follow-up of CTL019 in CLLSeptember 23, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
First-line BV can produce high response rate in older HL patientsSeptember 22, 2015Lymphoma & Plasma Cell DisordersHodgkin Lymphoma